Medical device

RefleXion will open a 50,000-square-foot manufacturing site later this month and add 50 employees by the end of the year.
Factory-CRO Group, a leading global contract research organization, is pleased to announce Sapna Hornyak as its new president and CEO and the appointment of Nick Thornton to chairman of its board of directors.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your ‘right opportunity’ to consider a new job.
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment.
Polarean Imaging announces that the total number of shares in issue and total voting rights as at the date of this announcement is 101,435,933 ordinary shares of £0.00037 each.
Expands Number of Managed Sites for Fast Clinical Trial Enrollment
Biom’up announced its full-year results for the year ending December 31, 2018, as approved by the Company’s Board of Directors on April 29, 2019, and provided an update on its operations.
According to a recent BioSpace survey, 93% of respondents are open to a new job for the right opportunity. Are you one of the 93%? If so, keep your eyes open for those opportunities and don’t stop looking. You never know what may come your way!
Polarean Imaging plc announces the appointment of Charles Osborne, Jr as Chief Financial Officer with immediate effect.
FDA
In September 2018 a leap forward in treating burn victims was made with the approval of Avita Medical’s RECELL Autologous Cell Harvesting Device. The Food and Drug Administration (FDA) green lit the California-based company’s burn treatment device that uses a small amount of a patient’s own skin to prepare what is called Spray-On Skin Cells.
PRESS RELEASES